⌕
National Health Investors · NHI · NYSE
Tenet 45 · Mixed
Compare
$60.77−3.46%At closeTenet 45 · Mixed
$60.77−2.18 (−3.46%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD

National Health Investors (NHI) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineSteady: revenue compounds ~5.9%/yr (FY21→FY25), net margin 37.5%; free cash flow runs at −27% of net income. Check the accrual gap. Worth your attention in FY25: Capex step-up ($274.1M) and Returns vs FCF (n/m). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲12.1%
375.6
FY21→FY25CAGR +5.9%/yr
Net income ($M)▲3.0%
140.8
FY21→FY25CAGR +5.9%/yr
Free cash flow ($M)—
−37.5
capex stepped upCAGR —
Diluted EPS▼3.5%
3.02
FY21→FY25CAGR +5.5%/yr
What the receipts whisper · what a headline number hides
Share count
+2.9%

45.7mn → 47.1mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.

Capex step-up
$274.1M

▲98% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.

Returns vs FCF
n/m

$171.4M returned vs $−37.5M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)375.6Revenue0.0COGS375.6Gross profit−26.9SG&A194.0Op income−53.2Tax & other140.8Net income

37¢ of every revenue dollar becomes profit.

Margin trend · direction beats level Gross Operating Net
10079583615%sector median net margin ~20%FY21FY25

Over this window: gross 100.0% → 100.0%. Net margin 37.5% is above the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
455,755.0375,628.0335,181.0319,835.0306,536.0298,715.0▲12.1%+5.9%
Cost of revenue
—0.00.00.00.00.0——
Gross profit
455,755.0375,628.0335,181.0319,835.0306,536.0298,715.0▲12.1%+5.9%
Selling, general & admin
32,282.026,868.020,736.019,314.022,768.018,431.0▲29.6%+9.9%
Total operating expenses
258,754.0181,593.0151,980.0142,719.0241,856.0216,139.0▲19.5%−4.3%
Operating incomefeeds ROC rank
197,001.0194,035.0183,201.0177,116.064,680.082,576.0▲5.9%+23.8%
Other income, net
497,796.0−56,912.0−46,964.0−43,290.0962.029,041.0——
Pretax income
694,797.0137,123.0136,237.0133,826.065,642.0111,617.0▲0.7%+5.3%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
696,126.0140,787.0136,639.0134,381.065,501.0111,967.0▲3.0%+5.9%
Per share
Diluted EPSbuyback-sensitive
14.243.023.133.131.482.44▼3.5%+5.5%
Diluted shares (mn)
49.0447.0544.1043.3944.7945.73▲6.7%+0.7%
Margins
Gross margin
100.0%100.0%100.0%100.0%100.0%100.0%▲0.0pp+0.0pp
Operating margin
43.2%51.7%54.7%55.4%21.1%27.6%▼3.0pp+24.0pp
Net margin82nd pct in Real Estate
152.7%37.5%40.8%42.0%21.4%37.5%▼3.3pp−0.0pp
† TTM = trailing four quarters through 2026-09-30.
FY08 – FY20 · 13 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 13 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-26 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was National Health Investors' revenue last fiscal year?

National Health Investors reported revenue of $375.6M in fiscal 2025, up 12.1% from fiscal 2024.

What was National Health Investors' net income?

National Health Investors reported net income of $140.8M in fiscal 2025, a net margin of 37.5%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.